about
Brahmi rasayana improves learning and memory in miceThe pharmacological landscape and therapeutic potential of serine hydrolasesDefensive effect of lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched dietSyncope secondary to second-degree atrioventricular block with donepezil useEffect of ethanolic extract of Acacia auriculiformis leaves on learning and memory in rats.The role of acetylcholine in cocaine addiction.Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease.Efficacy and safety of switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch in patients with probable Alzheimer's disease.Use of drugs with anticholinergic properties among nursing home residents with dementia: a national analysis of Medicare beneficiaries from 2007 to 2008.Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathwayTotal Lignans of Schisandra chinensis Ameliorates Aβ1-42-Induced Neurodegeneration with Cognitive Impairment in Mice and Primary Mouse Neuronal Cells.ABC Transporters and the Alzheimer's Disease Enigma.Galantamine Attenuates Type 1 Diabetes and Inhibits Anti-Insulin Antibodies in Non-Obese Diabetic MiceMitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeuticsSafety and efficacy of rivastigmine in patients with Alzheimer's disease not responding adequately to donepezil: an open-label studyLong-term safety and tolerability of rivastigmine in patients with Alzheimer's disease switched from donepezil: an open-label extension study.Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity.Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: implications for synaptic dysfunction and neuronal damageFocal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis.Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in ratsScreening the methanol extracts of some Iranian plants for acetylcholinesterase inhibitory activity.Investigations of anticholinestrase and antioxidant potentials of methanolic extract, subsequent fractions, crude saponins and flavonoids isolated from Isodon rugosus.Effect of Rheum Ribes Hydro-Alcoholic Extract on Memory Impairments in Rat Model of Alzheimer's Disease.Dynamic Brains and the Changing Rules of Neuroplasticity: Implications for Learning and Recovery.Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer's disease.Galantamine anti-colitic effect: Role of alpha-7 nicotinic acetylcholine receptor in modulating Jak/STAT3, NF-κB/HMGB1/RAGE and p-AKT/Bcl-2 pathways.
P2860
Q25257704-C0DEEF07-4ABD-4CE7-BEB4-C960D207D565Q26995817-3E04AE17-478C-4EA4-94CE-F34D70C7565FQ28535014-2ED796F4-E2E2-45FC-81DB-ACBDE512DC77Q33165044-AA77F636-6539-4E4E-B94A-7DBAB5107E20Q33840879-D2F8F389-CA95-4D0C-B2EA-6559F157E2E0Q34700186-B21062A4-C9E3-47C7-A6F5-3733412FEFD8Q35016920-DBEEA510-C413-4DF3-8750-CC6E080D2784Q35539649-52AB4312-FD4B-44C5-A31D-F427C34E1B63Q35924479-DB5F4E75-77E6-4ADE-B3AE-CD7221D39A72Q35944934-2CE8D946-5223-40DC-92DC-A39E3E598FD9Q35976705-6A183CA6-2316-498E-AEDA-4BBD0DBC4BCBQ36005085-38E44082-FD06-4B11-A0C8-613214344CFFQ36568311-27F307D8-C0E0-4CAB-AF28-A8422B6D795FQ36626374-6973606B-FF9C-4D56-91D8-184E4CCEE469Q36859507-34A632D3-58EC-4ED8-A71B-6FB910E32870Q37067950-AFE522AF-2507-403D-9812-FB9AEC19292CQ37213394-7FD8D0F0-7B53-41A8-B6D7-40EFE3013D69Q37302845-96418C3E-A8A5-4039-AE70-72CCEF162A39Q37315477-EF52810C-D85D-45ED-B817-4C8757F2F6C6Q37384908-F4CE1C70-1BEA-4C47-B3BF-0C2571AE672DQ41831076-4318AD61-039C-40F5-A89F-0FDC31B2F577Q42024680-B9008D08-FEBF-4242-ADEE-6E8D3DBDEB88Q42176085-C0EE59DD-94A4-469C-BE95-1263D6E6D53AQ43137643-2596EAD7-5A06-4DDC-99EC-0244B3C5C1DEQ46760489-E4422EFF-E02E-4B4D-BB10-E0072D37575DQ49643940-CFFE8283-4AAB-4047-AABC-6AF43A0E079BQ52639338-8F5466CA-04DC-486F-98F7-1BF638F6A73B
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cholinesterase inhibitors in the treatment of dementia.
@ast
Cholinesterase inhibitors in the treatment of dementia.
@en
type
label
Cholinesterase inhibitors in the treatment of dementia.
@ast
Cholinesterase inhibitors in the treatment of dementia.
@en
prefLabel
Cholinesterase inhibitors in the treatment of dementia.
@ast
Cholinesterase inhibitors in the treatment of dementia.
@en
P1476
Cholinesterase inhibitors in the treatment of dementia
@en
P2093
Jay M Ellis
P304
P407
P577
2005-03-01T00:00:00Z